Fate Therapeutics, Inc.FATENASDAQ
LOADING
|||
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-176.58M
↓ 43% below average
Average (9y)
$-123.62M
Historical baseline
Range
High:$-27.09M
Low:$-294.63M
CAGR
+23.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-176.58M | -2.5% |
| 2023 | $-172.23M | +41.5% |
| 2022 | $-294.63M | -39.5% |
| 2021 | $-211.14M | -68.9% |
| 2020 | $-125.00M | -32.7% |
| 2019 | $-94.20M | -47.9% |
| 2018 | $-63.70M | -56.5% |
| 2017 | $-40.71M | -31.6% |
| 2016 | $-30.94M | -14.2% |
| 2015 | $-27.09M | - |